Physician profile
David L Young
NPI 1699793190
$7,788.54
in general payments reported to CMS, 2019-2025
35 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $53.88 · 2021: $291 · 2022: $4,726 · 2023: $969 · 2024: $656 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,347.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,332.95 | 2019-2022 | |
| Stryker Corporation | $376.35 | 2022-2025 | Spy-Phi System, 1788, Photonsaber F |
| Ethicon US, LLC | $371.41 | 2019-2025 | Echelon Flex, Ethicon, Enseal |
| Medtronic, INC. | $338.68 | 2022-2025 | Endurant Iis, Ligasure, Signia |
| Integra Lifesciences Corporation | $229.75 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Myriad Genetic Laboratories, INC. | $203.01 | 2021-2023 | Myrisk |
| W. L. Gore & Associates, INC. | $196.75 | 2021-2025 | Gore Viabahn Endoprosthesis With Heparin |
| Innovation Technologies INC | $168.94 | 2022-2023 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $161.87 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $134.03 | 2021-2024 | Exparel |
| Vertex Pharmaceuticals Incorporated | $120.93 | 2025 | |
| Lemaitre Vascular, INC. | $117.52 | 2025 | Artegraft Vascular Graft |
| Shockwave Medical, INC | $99.89 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tela Bio, INC. | $91.14 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $80.70 | 2025 | Phasix Mesh |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $74.04 | 2020-2023 | V.A.C. Dermatac, Activ.A.C., 3m Cavilon |
| Acera Surgical, INC. | $72.95 | 2023-2024 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $70.40 | 2019-2023 | Keytruda |
| Heron Therapeutics, INC. | $62.08 | 2022-2024 | Zynrelef |
| Kls-Martin L.P. | $55.04 | 2023 | |
| Angiodynamics, INC. | $53.29 | 2025 | Angiovac |
| Lsi Solutions INC | $47.43 | 2022 | |
| Elucent Medical | $43.00 | 2022-2024 | |
| Corcym INC | $35.29 | 2023 | Perceval |
| Polynovo North America LLC | $34.94 | 2024 | Novosorb Btm |
| Hologic Sales and Service, LLC | $30.74 | 2023-2025 | Trident Specimen Radiography System, Coolseal Generator |
| Smith+Nephew, INC. | $28.83 | 2021-2024 | Collagenase Santyl |
| Ge Healthcare | $26.65 | 2022 | |
| Endomagnetics LTD | $26.01 | 2023 | Magtrace, Magseed |
| Edwards Lifesciences Corporation | $23.80 | 2022 | |
| Cardinal Health 414 LLC | $22.46 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Janssen Pharmaceuticals, INC | $19.27 | 2021 | |
| Misonix INC | $14.43 | 2020 | |
| Tactile Systems Technology INC | $12.72 | 2019 | |
| Osiris Therapeutics INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.